Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost-effectiveness analysis

Conclusion: For adults with T1DM in Canada, a connected insulin pen device is likely to be a cost-effective treatment option associated with greater clinical benefits and lower costs relative to a standard re-usable or disposable pen.PMID:38205726 | DOI:10.57264/cer-2023-0124
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Authors: Source Type: research